<?xml version="1.0" encoding="UTF-8"?>

<CodeSystem xmlns="http://hl7.org/fhir">
  <id value="ATCMixedCodes"/>
  <text>
    <status value="generated"/><div xmlns="http://www.w3.org/1999/xhtml"><p class="res-header-id"><b>Generated Narrative: CodeSystem ATCMixedCodes</b></p><a name="ATCMixedCodes"> </a><a name="hcATCMixedCodes"> </a><a name="ATCMixedCodes-en-US"> </a><p>This case-sensitive code system <code>https://kip.rkkp.dk/fhir/CodeSystem/ATCMixedCodes</code> defines the following codes in an undefined hierarchy:</p><table class="codes"><tr><td><b>Lvl</b></td><td style="white-space:nowrap"><b>Code</b></td><td><b>Display</b></td><td><b>Definition</b></td></tr><tr><td>1</td><td style="white-space:nowrap">tki<a name="ATCMixedCodes-tki"> </a></td><td>TKI (Tyrosine kinase inhibitors)</td><td>TKI (Tyrosine kinase inhibitors)</td></tr><tr><td>2</td><td style="white-space:nowrap">  L01EA<a name="ATCMixedCodes-L01EA"> </a></td><td>BCR-ABL tyrosine kinase inhibitors</td><td/></tr><tr><td>2</td><td style="white-space:nowrap">  L01EB<a name="ATCMixedCodes-L01EB"> </a></td><td>Epidermal growth factor receptor (EGFR) tyrosine kinase inhibitors</td><td/></tr><tr><td>2</td><td style="white-space:nowrap">  L01EH<a name="ATCMixedCodes-L01EH"> </a></td><td>Human epidermal growth factor receptor 2 (HER2) tyrosine kinase inhibitors</td><td/></tr><tr><td>2</td><td style="white-space:nowrap">  L01EK<a name="ATCMixedCodes-L01EK"> </a></td><td>Vascular endothelial growth factor receptor (VEGFR) tyrosine kinase inhibitors</td><td/></tr><tr><td>2</td><td style="white-space:nowrap">  L01EN<a name="ATCMixedCodes-L01EN"> </a></td><td>Fibroblast growth factor receptor (FGFR) tyrosine kinase inhibitors</td><td/></tr></table></div>
  </text>
  <url value="https://kip.rkkp.dk/fhir/CodeSystem/ATCMixedCodes"/>
  <version value="2.9.3"/>
  <name value="ATCMixedCodes"/>
  <title value="WHO ATC; Mixed codes"/>
  <status value="active"/>
  <date value="2022-07-14T00:00:00+02:00"/>
  <publisher value="Sundhedsvæsenets Kvalitetsinstitut with Trifork Digital Health A/S"/>
  <contact>
    <name value="Sundhedsvæsenets Kvalitetsinstitut with Trifork Digital Health A/S"/>
    <telecom>
      <system value="url"/>
      <value value="https://trifork.com"/>
    </telecom>
    <telecom>
      <system value="email"/>
      <value value="rbk@trifork.com"/>
    </telecom>
  </contact>
  <description value="WHO ATC code system; Mixed codes. Link: http://www.whocc.no/atc"/>
  <caseSensitive value="true"/>
  <content value="complete"/>
  <count value="6"/>
  <concept>
    <code value="tki"/>
    <display value="TKI (Tyrosine kinase inhibitors)"/>
    <definition value="TKI (Tyrosine kinase inhibitors)"/>
    <concept>
      <code value="L01EA"/>
      <display value="BCR-ABL tyrosine kinase inhibitors"/>
    </concept>
    <concept>
      <code value="L01EB"/>
      <display value="Epidermal growth factor receptor (EGFR) tyrosine kinase inhibitors"/>
    </concept>
    <concept>
      <code value="L01EH"/>
      <display value="Human epidermal growth factor receptor 2 (HER2) tyrosine kinase inhibitors"/>
    </concept>
    <concept>
      <code value="L01EK"/>
      <display value="Vascular endothelial growth factor receptor (VEGFR) tyrosine kinase inhibitors"/>
    </concept>
    <concept>
      <code value="L01EN"/>
      <display value="Fibroblast growth factor receptor (FGFR) tyrosine kinase inhibitors"/>
    </concept>
  </concept>
</CodeSystem>